Bosulif (Bosutinib)
- Medicine Name: Bosulif
- Generic Name: Bosutinib
- Dosage Form & Strength: Tablets: 100 mg/400 mg/500 mg, and Capsules 50 mg/100 mg
- Manufactured By: Pfizer
Alternative Option:
- Brand Name: Bosuvi
- Generic Name: Bosutinib
- Dosage Form & Strength: Tablets: 100 mg/400 mg/500 mg
- Company: Glenmark Pharmaceuticals Ltd
- Country of Origin: India
Medical Uses
Bosulif (bosutinib) is a kinase inhibitor used to treat chronic myelogenous leukemia (CML) in adults and children aged 1 year and older. It is prescribed for patients in the chronic phase of Philadelphia chromosome-positive (Ph+) CML, whether they are newly diagnosed or have not responded well to previous treatments. Additionally, Bosulif is used in adults with advanced stages of Ph+ CML, such as the accelerated or blast phase, when they have shown resistance or intolerance to prior therapies.
Recommended Dosage: Take the recommended dose of Bosulif once a day with food. Swallow the tablets whole—do not cut, crush, break, or chew them. Continue using Bosulif until your doctor advises stopping due to disease progression or side effects.
Capsules should also be swallowed whole. If you have trouble swallowing capsules, you can open them and mix the contents with applesauce or yogurt. However, this mixture should not replace a full meal.
If you miss a dose and more than 12 hours have passed, skip that dose and take your next scheduled dose at the usual time the following day.
- Dosage in Adult Patients with Newly-Diagnosed CP Ph+ CML: The recommended dosage of Bosulif is 400 mg orally once daily with food.
- Dosage in Adult Patients with CP, AP, or BP Ph+ CML with Resistance or Intolerance to Prior Therapy: The recommended dosage of Bosulif is 500 mg orally once daily with food.
- Dosage in Pediatric Patients with Newly-Diagnosed CP Ph+ CML or with CP Ph+ CML with Resistance or Intolerance to Prior Therapy: The recommended dose of Bosulif for pediatric patients with newly diagnosed CP Ph+ CML is 300 mg/m2 orally once daily with food and the recommended dosage for pediatric patients with CP Ph+ CML that is resistant or intolerant to prior therapy is 400 mg/m2 orally once daily with food.
Warning & Precautions
- Bosutinib can cause problems with your stomach and intestines, such as diarrhea, nausea, vomiting, and stomach pain. These issues can sometimes be severe. It’s important to stay hydrated and talk to your doctor if these symptoms become troublesome.
- This drug can lower your blood cell counts, which might increase the risk of infections, anemia, or bleeding. Regular blood tests are necessary to monitor your blood cell levels. If you notice unusual bruising, bleeding, or signs of infection like fever, contact your healthcare provider right away.
- Treatment with Bosutinib may affect your liver. Symptoms of liver problems can include yellowing of the skin or eyes (jaundice), dark urine, or pain in the upper right side of your abdomen. Regular liver function tests are important to check for any issues.
- This medication can cause heart problems, such as heart failure or irregular heartbeats. If you experience symptoms like chest pain, rapid heartbeat, shortness of breath, or swelling in your legs, seek medical attention immediately.
- Bosutinib tablets/capsules can cause your body to hold onto excess fluid, leading to swelling, especially in the hands, feet, or around the eyes. Report any significant swelling or sudden weight gain to your doctor.
- Kidney problems can occur with Bosulif. Symptoms might include decreased urine output, swelling, or unexplained fatigue. Your doctor will monitor your kidney function with blood tests during treatment.
- Bosulif can harm an unborn baby. Women who are pregnant, planning to become pregnant, or could become pregnant should avoid taking this medication. Effective birth control should be used during treatment.
- It is not known if Bosulif passes into breast milk, but due to potential risks, women should not breastfeed while taking this medication. Speak with your healthcare provider about alternatives.
Documentation & Availability
What documents are required to import BOSULIF to India?
BOSULIF (bosutinib) tablets/capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation are needed to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is BOSULIF available in India?
BOSULIF (bosutinib tablets/capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input:
- On availability of Bosulif in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
- Medicine Price.
- Finding Genuine and reliable sources from Canada, Europe, the USA, and Australia
- Ensuring 100% transparency.
BOSULIF can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of BOSULIF (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).
Please contact +91 9310090915 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for Bosulif tablets/capsules price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
Indian Pharma Network (IPN) can source BOSULIF (a cancer treatment medication) from across the globe and supply it to India and other countries where the medicine is not yet approved or unavailable. Through our services, we ensure that patients have worldwide access to the best available treatments.
IPN is capable of dispensing any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address directly from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Bosulif®?
Bosutinib is the Generic Name for the trade name drug Bosulif®.
What is the Manufacturer’s Name of Bosulif®?
Bosulif® is manufactured by Pfizer.
Is Bosulif® approved by the FDA?
Yes, Bosulif® is approved by the FDA. Date of first approval: September 4, 2012.
What is the dosage and form of Bosulif® supplied?
Bosulif® is supplied as Tablets: 150 mg, and 100 mg for oral administration.
What are the most common side effects of Bosulif®?
The most common side effects of Bosulif® are vomiting, nausea, diarrhea, abdominal pain, rash, fatigue, headache, pyrexia, hepatic dysfunction, decreased appetite respiratory tract infection, and constipation.
Where can I Access Bosulif® (bosutinib tablets) at the best price in India?
Indian Pharma Network (IPN), a certified pharmaceutical facilitator/supplier/importer and WHO-GDP certified offers Bosulif (bosutinib tablets) in India. Although FDA-approved Bosutinib (brand name Bosulif) is not yet registered in India, Indian patients can purchase it upon request at the lowest price. To confirm an order for Bosulif, a valid doctor’s prescription and, if required, an import permit must be submitted.
How much does Bosulif® (bosutinib tablets) cost in India?
Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on Bosutinib tablets cost in India, it is recommended to Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
Can Bosulif® (bosutinib tablets) be made available in SAARC countries?
Apart from Gulf countries, Bosulif® can be available in SAARC countries (Afghanistan, India, Bangladesh, Bhutan, Maldives, Nepal, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Bosulif® (bosutinib capsules/tablets) in these countries, ensuring access to this therapeutic drug through legal and reliable channels.
Is it safe to buy Bosulif® (bosutinib tablets) online in India?
Yes, one can buy Bosulif (bosutinib) online in India at the best price from the Indian Pharma Network (IPN) if this medicinal product is not registered or is unavailable in their country. We can help facilitate the supply of Bosulif® tablets through legal channels.
What are the storage conditions of Bosulif®?
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Store and dispense it in the original container.
In India, where has the Indian Pharma Network (IPN) imported and delivered anti-cancer medicines, including FDA-approved Bosutinib (brand name Bosulif)?
For personal use, FDA-approved Bosutinib (brand name Bosulif) can be accessed in India through our services. We have successfully imported and delivered anti-cancer medicines to these cities: Bangalore, Ahmedabad, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi,, Gurugram, Delhi Amaravati, Itanagar, Dispur, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain, Aurangabad, Barshi, Cachar, Dibrugarh, Kollam, Meghalaya, Mizoram, Sikkim, Puducherry, Punjab, Tripura, New Delhi, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, etc.
FAQs for Generic Brand Bosuvi (Bosutinib 100 MG/400 MG/500 MG)
What is Bosuvi (Bosutinib 100 mg/400 mg/500 mg)?
Bosuvi is an Indian generic brand that serves as an alternative to the brand-name medication Bosulif. It contains the active ingredient Bosutinib, which is used for the treatment of patients with chronic myelogenous leukemia (CML).
Is Bosuvi (Bosutinib) available for export from India?
Yes, we are a leading exporter of Bosuvi (generic Bosulif) from India to various regions worldwide, including Asia, Australia, North America, South America, Central America, Eastern Europe, Western Europe, the Middle East, and Africa.
How can healthcare providers or patients access Bosuvi (Bosutinib) from India?
To buy Bosutinib 100 mg/400 mg/500 mg from India, healthcare providers or patients must provide a valid prescription and comply with the import regulations of the destination country. The Indian Pharma Network (IPN) assists in navigating these requirements to ensure smooth delivery.
Where can I get Bosuvi (Bosutinib 100 mg/400 mg/500 mg) at the best Price?
Order Bosutinib at the best price today. We request that you Call/WhatsApp us at +91-9310090915, dial our TOLL-FREE Number: 1800-889-1064, or write to us at info@indianpharmanetwork.in. We are fully committed to providing you with the best Bosutinib 100 mg/400 mg/500 mg price from India. That is why we’ll match the cost/price of any other facilitators/suppliers/distributors in the market who require a valid medical prescription.
Is the Bosuvi (Bosutinib 100 mg/400 mg/500 mg) available in India?
Bosuvi (Bosutinib) is a generic alternative to Bosulif and is available in India. It is a (prescription drug, doctor-prescribed medication, or health care professional-prescribed medicine) pharmaceutical drug that can be legally dispensed against a medical prescription. A generic version of Bosulif can be made available across the world through India’s authorized distributor network. (Ahmedabad, Mumbai, Kolkata, Hyderabad, Bangalore, Chennai, Delhi, Pune, etc.).
Can You Send the Bosuvi (Bosutinib 100 mg/400 mg/500 mg) to Foreign Destinations?
Buy generic Bosutinib online at the lowest price from a leading supplier/exporter. We can assist in the delivery of Bosutinib; the doctor-prescribed medication to Austria, Belgium, France, Germany, Ireland, Luxembourg, Netherlands, Switzerland, the UK, Israel, Iraq, Jordan, Bahrain, Egypt, Iran, Kuwait, Qatar, Lebanon, Oman, Saudi Arabia, Syria, Turkey, UAE, Belize, Costa Rica, El Salvador, Guatemala, Italy, Czech Republic, Panama, Serbia, Slovakia, Slovenia, Ukraine, Russia, Bulgaria, Croatia, Estonia, Hungary, Kosovo, Latvia, Lithuania, Moldova, Poland, Romania, Belarus, Argentina, Brazil, Chile, Colombia, Guyana, Peru, Ecuador, Paraguay, Suriname, Uruguay, Venezuela, Canada, Mexico, US, Singapore, Japan, Sri Lanka, Indonesia, and China.
What is the procedure for buying Bosuvi (Bosutinib 100 mg/400 mg/500 mg) from India?
Patients can simply fill out the order form or send mail to info@indianpharmanetwork.in. Patients can also send WhatsApp messages to +91-9310090915 or dial the TOLL-FREE Number: 18008891064. We will reply ASAP with the details of the Bosutinib 100 mg/400 mg/500 mg price and the procurement procedure.
Note:- The order will be confirmed only after the valid receipt of the prescription from the Physician.
Is it safe to buy Bosuvi (Bosutinib) Tablets online from India?
Yes, one can buy Bosutinib tablets online from India-based Indian Pharma Network (IPN) if the medicinal product is not (yet) registered or is unavailable in their respective country. We can help facilitate the supply of generic Bosutinib through legal channels.
What are the main export markets for Bosuvi (Bosutinib 100 mg/400 mg/500 mg)?
The main export markets for Bosuvi (Bosutinib 100 mg/400 mg/500 mg tabletss) are Western Europe (Austria, Belgium, France, Germany, Ireland, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland, United Kingdom, Andorra), Australia, the Middle East (Bahrain, Cyprus, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, Turkey, UAE, Yemen), Central America (Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama), Eastern Europe (Serbia, Slovakia, Slovenia, Ukraine, Russia, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Kosovo, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Poland, Romania, Albania, Belarus, Bosnia, Herzegovina), South America (Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela), Asia (Vietnam, Thailand, Singapore, Sri Lanka, Philippines, Maldives, Malaysia, Japan, Indonesia, China, Bangladesh, Bhutan, Afghanistan), North America (Canada, Mexico, US, Cuba, Jamaica, Haiti, and Africa.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
